The Ohio State University Wexner Medical Center Archives

Ohio State Researchers Use Gene Therapy to Treat Children with Rare AADC Disease

Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency, Children, Clinical Studies, Gene Therapy, Genetic Diseases, Nature Communications, R&D, Rare Diseases, Scientists, The Ohio State University Wexner Medical Center

A study found potential in a novel gene therapy method to help children born with a rare genetic and neurodegenerative disorder, AADC deficiency.

July 13, 2021/by BioSpace

A new study by researchers at the University College London (UCL) published in Lancet Infectious Diseases finds that although the U.K. variant of SARS-CoV-2 known as B.1.1.7 is more transmissible than the wild-type, original Wuhan strain, it is likely not more deadly.

Newly Discovered Immune Cell May Rescue and Reverse Nerve Damage

ALS, Immune Cells, Immunotherapeutics, Multiple Sclerosis, Nerve Cells, Neurodegenerative Diseases, Optic Nerves, Pro-regenerative cells, The Ohio State University Wexner Medical Center, University of Michigan

A pro-regenerative cell discovered by researchers at Ohio State and the University of Michigan could open the door to potentially groundbreaking immunotherapeutic treatments for diseases such as ALS and multiple sclerosis.